AFFINIA THERAPEUTICS Trademark

Trademark Overview

On Thursday, February 27, 2020, a trademark application was filed for AFFINIA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the AFFINIA THERAPEUTICS trademark a serial number of 88813905. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 20, 2024. This trademark is owned by TDTx Inc.. The AFFINIA THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Gene therapy products, namely biopharmaceutical preparations, primarily comprised of adeno-associated virus (AAV) vectors comprising a transgene for delivery to a cell or tissue, for the treatment of rare genetic diseases, conditions and disorders of muscle or the central nervous system; biological preparations as therapeutic products for medical use in medical and clinical gene therapy, namely, biological preparations for the treatment of rare genetic diseases, conditions and disorders of muscle or the central nervous system
affinia therapeutics

General Information

Serial Number88813905
Word MarkAFFINIA THERAPEUTICS
Filing DateThursday, February 27, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 16, 2021

Trademark Statements

Goods and ServicesGene therapy products, namely biopharmaceutical preparations, primarily comprised of adeno-associated virus (AAV) vectors comprising a transgene for delivery to a cell or tissue, for the treatment of rare genetic diseases, conditions and disorders of muscle or the central nervous system; biological preparations as therapeutic products for medical use in medical and clinical gene therapy, namely, biological preparations for the treatment of rare genetic diseases, conditions and disorders of muscle or the central nervous system
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 5, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAFFINIA THERAPEUTICS INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453
Party NameAFFINIA THERAPEUTICS INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressWALTHAM, MA 02453
Party NameTDTx Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Thursday, March 5, 2020NEW APPLICATION ENTERED
Thursday, March 5, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 20, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, May 15, 2020ASSIGNED TO EXAMINER
Monday, May 25, 2020NON-FINAL ACTION E-MAILED
Monday, May 25, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 25, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 25, 2020NON-FINAL ACTION WRITTEN
Tuesday, November 24, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 24, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 11, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 27, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 16, 2021PUBLISHED FOR OPPOSITION
Tuesday, February 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 28, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, July 28, 2021SOU EXTENSION 1 FILED
Wednesday, July 28, 2021SOU EXTENSION 1 GRANTED
Tuesday, April 13, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 25, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 25, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 25, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, May 25, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 3, 2022SOU TEAS EXTENSION RECEIVED
Thursday, March 3, 2022SOU EXTENSION 2 FILED
Thursday, March 3, 2022SOU EXTENSION 2 GRANTED
Tuesday, September 6, 2022SOU TEAS EXTENSION RECEIVED
Saturday, March 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 6, 2022SOU EXTENSION 3 FILED
Tuesday, September 6, 2022SOU EXTENSION 3 GRANTED
Thursday, September 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 9, 2023SOU EXTENSION 4 GRANTED
Thursday, March 9, 2023SOU TEAS EXTENSION RECEIVED
Thursday, March 9, 2023SOU EXTENSION 4 FILED
Saturday, March 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 15, 2023SOU TEAS EXTENSION RECEIVED
Friday, September 15, 2023SOU EXTENSION 5 FILED
Thursday, September 21, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 21, 2023SOU EXTENSION 5 GRANTED
Friday, September 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 2, 2023AMENDMENT AFTER NOA NOT ENTERED
Thursday, November 2, 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, May 20, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, May 20, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

therapeutics affinia preparations conditions disorders muscle central gene rare treatment diseases nervous